Maresin-1 Attenuates Acute Pentylenetetrazol-Induced Chemoconvulsive Activity and Associated Molecular Changes and Behavioural Impairments in Rats


Zaqzouq D., Torun I. E., Deniz O. G., Him A., KILINÇ E.

Iranian Journal of Science, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1007/s40995-026-02075-1
  • Dergi Adı: Iranian Journal of Science
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Acute chemoconvulsive activity, Maresin-1, Memory, Neuroinflammation, PTZ, Seizure-like activity
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Neuroinflammatory mechanisms represent critical therapeutic targets in epilepsy, given their established contribution to heightened neuronal excitability and disease pathology. Maresin-1, an endogenous specialized pro-resolving lipid mediator, exhibits potent anti-inflammatory and neuroprotective properties through its role in active inflammation resolution. This study investigated the effects of maresin-1 on acute PTZ-induced chemoconvulsive activity, associated neuroinflammatory and astroglial responses, and cognitive performance in rats. Rats were randomly assigned to seven groups (n = 12/group) receiving intraperitoneal injections: vehicle, PTZ, maresin-1 (0.4 or 4 µg/kg) and valproic acid in different combinations. Seizure-like behaviours were evaluated using Racine’s scale and cognitive performance was assessed by passive avoidance test. Cortical and hippocampal levels of TNF-α, IL-1β, GFAP, and BDNF were quantified by ELISA. Maresin-1 delayed the onset of the first myoclonic jerk and generalized tonic–clonic seizure behaviours and reduced the overall severity of PTZ-induced seizure-like activity. It also prolonged cognitive performance-associated step-through latency during the retention trial of the passive avoidance test in the PTZ-induced chemoconvulsive conditions. Moreover, it modulated levels of biochemical markers (TNF-α, IL-1β, GFAP, and BDNF) in the cortex and hippocampus. Valproic acid, used as a positive control, markedly prevented PTZ-induced behavioural and biochemical changes. Maresin-1 attenuated acute PTZ-induced chemoconvulsive activity and associated cognitive and molecular alterations in rats. These findings suggest that maresin-1 modulates behavioural and neurochemical responses associated with acute chemoconvulsive activity. Further studies using chronic seizure models are required to determine whether these effects extend to epilepsy or epileptogenesis.